These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35369074)

  • 1. Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.
    Wang ZX; Wang MY; Yang RX; Zhao ZH; Xin FZ; Li Y; Ren TY; Fan JG
    Front Nutr; 2022; 9():808497. PubMed ID: 35369074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations.
    Pichon C; Nachit M; Gillard J; Vande Velde G; Lanthier N; Leclercq IA
    Front Nutr; 2022; 9():1051157. PubMed ID: 36466421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models.
    Nachit M; De Rudder M; Thissen JP; Schakman O; Bouzin C; Horsmans Y; Vande Velde G; Leclercq IA
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):144-158. PubMed ID: 33244884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
    Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
    Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azilsartan Ameliorates Skeletal Muscle Wasting in High Fat Diet (HFD)-induced Sarcopenic Obesity in Rats via Activating Akt Signalling Pathway.
    Prajapati P; Kumar A; Singh J; Saraf SA; Kushwaha S
    Arch Gerontol Geriatr; 2023 Sep; 112():105025. PubMed ID: 37062187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62/Sqstm1 rescue in muscle retards the progression of steatohepatitis in
    Miura I; Okada K; Ishii A; Warabi E; Watahiki T; To K; Shimano H; Ariizumi S; Shoda J
    Front Physiol; 2022; 13():993995. PubMed ID: 36439272
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Kuraji R; Ito H; Fujita M; Ishiguro H; Hashimoto S; Numabe Y
    Clin Exp Dent Res; 2016 Dec; 2(3):216-225. PubMed ID: 29744170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Codonopsis lanceolata ameliorates sarcopenic obesity via recovering PI3K/Akt pathway and lipid metabolism in skeletal muscle.
    Han MJ; Choung SY
    Phytomedicine; 2022 Feb; 96():153877. PubMed ID: 35026519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Kumar A; Davuluri G; Silva RNE; Engelen MPKJ; Ten Have GAM; Prayson R; Deutz NEP; Dasarathy S
    Hepatology; 2017 Jun; 65(6):2045-2058. PubMed ID: 28195332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
    Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
    J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men.
    Drescher HK; Schippers A; Rosenhain S; Gremse F; Bongiovanni L; Bruin A; Eswaran S; Gallage SU; Pfister D; Szydlowska M; Heikenwalder M; Weiskirchen S; Wagner N; Trautwein C; Weiskirchen R; Kroy DC
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Administration of Panax Ginseng Berry Extract Attenuates High-Fat-Diet-Induced Sarcopenic Obesity in C57BL/6 Mice.
    Shin JE; Jeon SH; Lee SJ; Choung SY
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
    Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
    Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
    Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake.
    Hwang S; Ren T; Gao B
    Clin Mol Hepatol; 2020 Oct; 26(4):586-594. PubMed ID: 32937687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnitine prevents metabolic steatohepatitis in obese diabetic KK-A
    Kon K; Ikejima K; Morinaga M; Kusama H; Arai K; Aoyama T; Uchiyama A; Yamashina S; Watanabe S
    Hepatol Res; 2017 Mar; 47(3):E44-E54. PubMed ID: 27062266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors.
    Ponnusamy S; Tran QT; Thiyagarajan T; Miller DD; Bridges D; Narayanan R
    Exp Biol Med (Maywood); 2017 Mar; 242(6):606-616. PubMed ID: 28092182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.